| Income Statement |
| Operating Expenses | 1.42M |
|
| Research and Development Expense | 106.41K |
| Selling, General and Administrative Expense | 1.31M |
| Operating Income | -1.42M |
| Interest Expense | -58.36K |
| Net Income | -19.87M |
| Net Income Common Stock | -19.87M |
| Net Income Common Stock (USD) | -19.87M |
| Consolidated Income | -19.87M |
| Earnings per Basic Share | -1.33 |
| Earnings per Basic Share (USD) | -1.33 |
| Earnings per Diluted Share | -1.33 |
| Earning Before Interest & Taxes (EBIT) | -19.93M |
| Earning Before Interest & Taxes (USD) | -19.93M |
| Weighted Average Shares | 14.94M |
| Weighted Average Shares Diluted | 14.94M |
| Balance Sheet |
| Cash and Equivalents | 20.16M |
| Cash and Equivalents (USD) | 20.16M |
| Current Assets | 20.36M |
| Property, Plant & Equipment Net | 8.19M |
| Total Assets | 28.55M |
| Current Liabilities | 579.25K |
| Total Liabilities | 1.98M |
| Accumulated Retained Earnings (Deficit) | -30.38M |
| Shareholders Equity | 26.57M |
| Shareholders Equity (USD) | 26.57M |
| Assets Non-Current | 8.19M |
| Liabilities Non-Current | 1.40M |
| Trade and Non-Trade Payables | 579.25K |
| Tax Liabilities | 1.40M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.67K |
| Net Cash Flow from Financing | 22.68M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 20.07M |
| Issuance (Purchase) of Equity Shares | 22.68M |
| Net Cash Flow from Operations | -2.60M |
| Share Based Compensation | 17.75M |